was read the article
array:23 [ "pii" => "S1578219019301258" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.10.024" "estado" => "S300" "fechaPublicacion" => "2019-06-01" "aid" => "2108" "copyright" => "Elsevier España, S.L.U. and AEDV" "copyrightAnyo" => "2019" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2019;110:337" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 35 "HTML" => 35 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731018305052" "issn" => "00017310" "doi" => "10.1016/j.ad.2018.10.011" "estado" => "S300" "fechaPublicacion" => "2019-06-01" "aid" => "2108" "copyright" => "AEDV" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2019;110:337" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 325 "formatos" => array:2 [ "HTML" => 212 "PDF" => 113 ] ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>" "titulo" => "Carcinoma de células de Merkel, un tumor en auge" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "337" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "The Rising Incidence of Merkel Cell Carcinoma" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "B. Llombart" "autores" => array:1 [ 0 => array:2 [ "nombre" => "B." "apellidos" => "Llombart" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219019301258" "doi" => "10.1016/j.adengl.2018.10.024" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019301258?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731018305052?idApp=UINPBA000044" "url" => "/00017310/0000011000000005/v1_201906020639/S0001731018305052/v1_201906020639/es/main.assets" ] ] "itemSiguiente" => array:18 [ "pii" => "S1578219019301428" "issn" => "15782190" "doi" => "10.1016/j.adengl.2018.12.011" "estado" => "S300" "fechaPublicacion" => "2019-06-01" "aid" => "2142" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2019;110:338" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "The Many Faces of Seborrheic Keratosis" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "338" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Las posibles mil caras de las queratosis seborreicas" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Carrera" "autores" => array:1 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Carrera" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731019300134" "doi" => "10.1016/j.ad.2018.12.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731019300134?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019301428?idApp=UINPBA000044" "url" => "/15782190/0000011000000005/v1_201906050857/S1578219019301428/v1_201906050857/en/main.assets" ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Commentaries</span>" "titulo" => "The Rising Incidence of Merkel Cell Carcinoma" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:1 [ "paginaInicial" => "337" ] ] "autores" => array:1 [ 0 => array:3 [ "autoresLista" => "B. Llombart" "autores" => array:1 [ 0 => array:3 [ "nombre" => "B." "apellidos" => "Llombart" "email" => array:1 [ 0 => "Beatriz.llombart@uv.es" ] ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Dermatología, Instituto Valenciano de Oncología, Valencia, Spain" "identificador" => "aff0005" ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Carcinoma de células de Merkel, un tumor en auge" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Merkel cell carcinoma (MCC) is considered an orphan disease due to its very low incidence. The article by Dañino-García et al.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a> reports on a series of 38 patients with MCC treated at their hospital over a period of 16 years. The authors found a 116% increase in the number of cases diagnosed in the second half of the study and also observed an increase in the age of diagnosis and the occurrence of tumors at atypical sites. The increase in incidence is due to greater familiarity with the disease among dermatologists and pathologists and an increase in the at-risk population due to UV exposure, aging, and immunosuppression.</p><p id="par0010" class="elsevierStylePara elsevierViewall">MCC is a fast-growing, highly aggressive tumor characterized by early lymph node metastasis and high mortality. Mortality rates are much higher than for melanoma, for example, with a 10-year survival rate of 17.7% for MCC versus 61.3% for melanoma.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">2</span></a> The overall 24-month survival rate in this series of 38 patients was 69.3% and the strongest prognostic factor was lymph node metastasis.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">1</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Effective medical treatment is needed for metastatic MCC. Conventional first-line chemotherapy is associated with response rates of between 30% and 55%, but response is short-lived (<span class="elsevierStyleBold"><<span class="elsevierStyleHsp" style=""></span></span>5 months).<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a> Second-line chemotherapy does not offer any significant survival benefit, with a 12-month survival rate of 0%.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">3</span></a> The European Medicines Agency recently approved avelumab for the treatment of metastatic MCC. First-line avelumab induces rapid response in 62% to 74% of patients, and 52% of patients who receive this drug as second-line therapy are still alive at 12 months.<a class="elsevierStyleCrossRefs" href="#bib0035"><span class="elsevierStyleSup">3,4</span></a> The emergence of these new immunotherapy agents brings new hope to patients with MCC.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Llombart B. Carcinoma de células de Merkel, un tumor en auge. Actas Dermosifiliogr. 2019;110:337.</p>" ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:4 [ 0 => array:3 [ "identificador" => "bib0025" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Características clínico-epidemiológicas del carcinoma de Merkel en una serie de 38 pacientes" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "M. Dañino-García" 1 => "J. Domínguez-Cruz" 2 => "C. Pérez-Ruiz" 3 => "J. Conejo-Mir" 4 => "J.J. Pereyra-Rodriguez" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2018.09.007" "Revista" => array:2 [ "tituloSerie" => "Actas Dermosifilogr" "fecha" => "2018" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0030" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A comparison of Merkel cell carcinoma and melanoma: Results from the California Cancer Registry" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J. Grabowski" 1 => "S.L. Saltzstein" 2 => "G.R. Salder" 3 => "Z. Tahir" 4 => "S. Blair" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Clin Med Oncol" "fecha" => "2008" "volumen" => "2" "paginaInicial" => "327" "paginaFinal" => "333" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21892294" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0035" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Real-world treatment outcomes in patients with metastatic Merkel cell carcinoma treated with chemotherapy in the USA" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "C.L. Cowey" 1 => "L. Mahnke" 2 => "J. Espirito" 3 => "C. Helwig" 4 => "D. Oksen" 5 => "M. Bharmal" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2217/fon-2017-0187" "Revista" => array:6 [ "tituloSerie" => "Future Oncol" "fecha" => "2017" "volumen" => "13" "paginaInicial" => "1699" "paginaFinal" => "1710" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28605939" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0040" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of advanced Merkel cell carcinoma: Current therapeutic options and novel immunotherapy approaches" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "D. Femia" 1 => "N. Prinzi" 2 => "A. Anichini" 3 => "R. Mortarini" 4 => "F. Nichetti" 5 => "F. Corti" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Target Oncol" "fecha" => "2018" "volumen" => "13" "paginaInicial" => "567" "paginaFinal" => "582" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000011000000005/v1_201906050857/S1578219019301258/v1_201906050857/en/main.assets" "Apartado" => array:4 [ "identificador" => "66476" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Commentaries" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000011000000005/v1_201906050857/S1578219019301258/v1_201906050857/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219019301258?idApp=UINPBA000044" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 15 | 10 | 25 |
2024 October | 65 | 29 | 94 |
2024 September | 67 | 18 | 85 |
2024 August | 107 | 63 | 170 |
2024 July | 70 | 23 | 93 |
2024 June | 73 | 27 | 100 |
2024 May | 63 | 31 | 94 |
2024 April | 59 | 21 | 80 |
2024 March | 61 | 24 | 85 |
2024 February | 44 | 28 | 72 |
2024 January | 58 | 32 | 90 |
2023 December | 40 | 14 | 54 |
2023 November | 62 | 24 | 86 |
2023 October | 52 | 30 | 82 |
2023 September | 37 | 28 | 65 |
2023 August | 27 | 13 | 40 |
2023 July | 33 | 34 | 67 |
2023 June | 36 | 21 | 57 |
2023 May | 33 | 21 | 54 |
2023 April | 28 | 28 | 56 |
2023 March | 27 | 19 | 46 |
2023 February | 31 | 24 | 55 |
2023 January | 29 | 21 | 50 |
2022 December | 33 | 27 | 60 |
2022 November | 27 | 34 | 61 |
2022 October | 27 | 22 | 49 |
2022 September | 19 | 34 | 53 |
2022 August | 28 | 40 | 68 |
2022 July | 22 | 36 | 58 |
2022 June | 23 | 27 | 50 |
2022 May | 33 | 27 | 60 |
2022 April | 38 | 34 | 72 |
2022 March | 35 | 65 | 100 |
2022 February | 36 | 22 | 58 |
2022 January | 34 | 40 | 74 |
2021 December | 25 | 28 | 53 |
2021 November | 37 | 40 | 77 |
2021 October | 36 | 56 | 92 |
2021 September | 28 | 38 | 66 |
2021 August | 25 | 21 | 46 |
2021 July | 20 | 18 | 38 |
2021 June | 17 | 12 | 29 |
2021 May | 20 | 32 | 52 |
2021 April | 47 | 49 | 96 |
2021 March | 55 | 16 | 71 |
2021 February | 50 | 29 | 79 |
2021 January | 25 | 8 | 33 |
2020 December | 15 | 13 | 28 |
2020 November | 10 | 8 | 18 |
2020 October | 11 | 10 | 21 |
2020 September | 29 | 6 | 35 |
2020 August | 24 | 11 | 35 |
2020 July | 26 | 12 | 38 |
2020 June | 21 | 21 | 42 |
2020 May | 16 | 12 | 28 |
2020 April | 16 | 8 | 24 |
2020 March | 18 | 11 | 29 |
2020 February | 1 | 0 | 1 |
2019 November | 35 | 0 | 35 |